Quince therapeutics to present at citizens life sciences conference

South san francisco, calif.--(business wire)---- $qncx #biotech--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that dirk thye, m.d., quince's chief executive officer and chief medical officer, will present at the citizens life sciences conference taking place in new york city on wednesday, may 7, 2025 beginning at 3:30 p.m. eastern time. a live webcast of the presentation.
QNCX Ratings Summary
QNCX Quant Ranking